linvoseltamab in patients with relapsed/refractory myeloma | suzanne lentzsch md, phd | eha 2024
Published 2 months ago • 172 plays • Length 5:37Download video MP4
Download video MP3
Similar videos
-
1:23
dr lentzsch on results for linvoseltamab in heavily pretreated r/r myeloma
-
1:25
safety and efficacy of linvoseltamab for patients with r/r multiple myeloma
-
2:12
safety and efficacy of linvoseltamab in patients with relapsed/refractory (r/r) multiple myeloma
-
1:33
updates from the linker-mm1 study: linvoseltamab in r/r multiple myeloma
-
37:11
mcrt new york 2018: bone disease and multiple myeloma by suzanne lentzsch, md phd
-
1:47
insights into the efficacy of linvoseltamab in the treatment of r/r multiple myeloma
-
2:29
phase i first-in-human study of alnuctamab in patients with r/r multiple myeloma
-
2:07
addition of lenalidomide to patients with myeloma progressing on ruxolitinib and methylprednisolone
-
4:45
a first-in-human trial of linvoseltamab (regn5458) in r/r myeloma: updated phase i data
-
1:23
association of sbcma with measures of disease burden & response to linvoseltamab in r/r myeloma
-
0:45
car t-cell therapy in lenalidomide-refractory multiple myeloma
-
1:10
latest developments in the treatment of emd in myeloma
-
0:59
understanding the role of immunoglobulins in multiple myeloma
-
2:11
perspectives on the treatment of patients with r/r multiple myeloma
-
1:06
improving outcomes for patients with r/r myeloma
-
0:36
what is multiple myeloma?
-
1:30
real-world treatment patterns in third-line therapy for r/r myeloma
-
0:47
sustained mrd for treatment guidance in myeloma